Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 14,726 | 11,279 | 9,920 | 12,162 | 8,296 |
| Cost of Goods | 6,753 | 4,826 | 4,499 | 4,568 | 3,051 |
| Gross Profit | 7,973 | 6,453 | 5,421 | 7,594 | 5,245 |
| Operating Expenses | 14,131 | 8,529 | 5,876 | 7,792 | 6,057 |
| Operating Income | -5,409 | -1,246 | 44 | 370 | -761 |
| Other Income | -667 | 113 | -16,424 | 21,938 | 2,203 |
| Pre-tax Income | -6,076 | -1,133 | -16,380 | 22,308 | 1,442 |
| Net Income Continuous | -2,812 | -1,133 | -16,380 | 22,308 | 2,983 |
| Net Income | $-2,812 | $-1,133 | $-16,380 | $22,308 | $2,983 |
| EPS Basic Total Ops | -0.06 | -0.04 | -0.70 | 0.87 | 0.34 |
| EPS Basic Continuous Ops | -0.25 | -0.04 | -0.70 | 1.06 | 0.20 |
| EPS Diluted Total Ops | 0.69 | -0.04 | -0.70 | -0.01 | 0.57 |
| EPS Diluted Continuous Ops | -0.25 | -0.04 | -0.70 | 1.06 | 0.36 |
| EBITDA(a) | $-3,891 | $-63 | $1,310 | $1,471 | $198 |